Affimed to Report Second Quarter 2022 Financial Results &
HEIDELBERG, Germany, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed”, or the “Company”), a clinical-stage immuno-oncology...
Source: globenewswire.com
Page 3 - Affimednv News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Affimednv . Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Affimednv Today - Breaking & Trending Today
Affimed N.V.: Q1 Earnings Snapshot
HEIDELBERG, Germany (AP) _ Affimed N.V. (AFMD) on Wednesday reported a first-quarter loss...
Source: manisteenews.com
Affimed to Present Preclinical Data Demonstrating Cytotoxic
The novel bispecific innate cell engager AFM28 stimulates NK cells to destroy CD123-positive tumor cells via antibody-dependent cellular cytotoxicity.AFM28...
Source: globenewswire.com
CORRECTING and REPLACING -- Affimed N.V.
In a press release issued earlier today by Affimed N.V. (Nasdaq: AFMD), please note that the headline named an incorrect organization. It should have...
Source: globenewswire.com
Affimed Announces Pricing of Upsized $90 Million Public
HEIDELBERG, Germany, April 12, 2022 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology...
Source: globenewswire.com